anmelden
AstraZeneca Aktie
149,85
EUR
+1,50
EUR
+1,01
%
149,80
EUR
+1,85
EUR
+1,25
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 14.12.12 | AstraZeneca hold | Deutsche Bank AG | |
| 12.12.12 | AstraZeneca underperform | Credit Suisse Group | |
| 12.12.12 | AstraZeneca hold | Deutsche Bank AG | |
| 06.12.12 | AstraZeneca hold | Deutsche Bank AG | |
| 19.11.12 | AstraZeneca hold | Deutsche Bank AG | |
| 14.11.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 30.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 29.10.12 | AstraZeneca underperform | Credit Suisse Group | |
|
Werbung
|
|||
| 26.10.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 25.10.12 | AstraZeneca neutral | Citigroup Corp. | |
| 23.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
| 17.10.12 | AstraZeneca buy | UBS AG | |
| 16.10.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 11.10.12 | AstraZeneca hold | Deutsche Bank AG | |
| 05.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 04.10.12 | AstraZeneca reduce | Nomura | |
| 04.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
| 03.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 02.10.12 | AstraZeneca hold | Deutsche Bank AG | |
| 26.09.12 | AstraZeneca overweight | Morgan Stanley | |
| 19.09.12 | AstraZeneca buy | UBS AG | |
| 12.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 10.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 04.09.12 | AstraZeneca neutral | Citigroup Corp. | |
| 29.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
| 29.08.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 29.08.12 | AstraZeneca neutral | Sarasin Research | |
| 28.08.12 | AstraZeneca hold | Deutsche Bank AG | |
| 27.08.12 | AstraZeneca hold | Deutsche Bank AG | |
| 21.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 17.08.12 | AstraZeneca underperform | Credit Suisse Group | |
| 16.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
| 06.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 02.08.12 | AstraZeneca reduce | Nomura | |
| 27.07.12 | AstraZeneca buy | UBS AG | |
| 27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 19.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 18.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 18.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 16.07.12 | AstraZeneca buy | UBS AG | |
| 12.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 03.07.12 | AstraZeneca buy | UBS AG | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 02.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 02.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
Werbung
Werbung